A global biotech company with local roots

Durham-based BioCryst Pharmaceuticals is a global, commercial-stage biotech company focused on rare diseases. While the company has existed for more than 35 years, BioCryst has recently undergone rapid expansion as the company launched its first drug for a rare disease. Throughout this transformational period, the BioCryst team has remained committed to putting patients at the heart of everything it does. By actively listening to and understanding the needs of patients, physicians, employees and other stakeholders, BioCryst has stayed true to its roots as the company strives to help patients take part in the everyday activities they enjoy.